BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 15632379)

  • 1. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
    Fong LY; Zhang L; Jiang Y; Farber JL
    J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice.
    Fong LY; Jiang Y; Farber JL
    Carcinogenesis; 2006 Jul; 27(7):1489-96. PubMed ID: 16543248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially expressed genes execute zinc-induced apoptosis in precancerous esophageal epithelium of zinc-deficient rats.
    Ishii H; Vecchione A; Furukawa Y; Croce CM; Huebner K; Fong LY
    Oncogene; 2004 Oct; 23(49):8040-8. PubMed ID: 15361827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide.
    Shiotani H; Denda A; Yamamoto K; Kitayama W; Endoh T; Sasaki Y; Tsutsumi N; Sugimura M; Konishi Y
    Cancer Res; 2001 Feb; 61(4):1451-6. PubMed ID: 11245450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice.
    Fong LY; Ishii H; Nguyen VT; Vecchione A; Farber JL; Croce CM; Huebner K
    Cancer Res; 2003 Jan; 63(1):186-95. PubMed ID: 12517797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; RosanĂ² L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of gene expression in precancerous rat esophagus by dietary zinc deficit and replenishment.
    Liu CG; Zhang L; Jiang Y; Chatterjee D; Croce CM; Huebner K; Fong LY
    Cancer Res; 2005 Sep; 65(17):7790-9. PubMed ID: 16140947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-difluoromethylornithine induction of apoptosis: a mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats.
    Fong LY; Nguyen VT; Pegg AE; Magee PN
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):191-9. PubMed ID: 11303587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
    Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
    Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac.
    Yamamoto K; Kitayama W; Denda A; Sasahira T; Kuniyasu H; Kirita T
    Pathobiology; 2006; 73(6):317-24. PubMed ID: 17374970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies.
    Suzuki R; Kohno H; Suzui M; Yoshimi N; Tsuda H; Wakabayashi K; Tanaka T
    Carcinogenesis; 2006 Mar; 27(3):619-30. PubMed ID: 16219633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
    Stoner GD; Qin H; Chen T; Carlton PS; Rose ME; Aziz RM; Dixit R
    Carcinogenesis; 2005 Sep; 26(9):1590-5. PubMed ID: 15878914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
    J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies.
    Miyamoto S; Yasui Y; Kim M; Sugie S; Murakami A; Ishigamori-Suzuki R; Tanaka T
    Carcinogenesis; 2008 Feb; 29(2):418-26. PubMed ID: 18174262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined cyclin D1 overexpression and zinc deficiency disrupts cell cycle and accelerates mouse forestomach carcinogenesis.
    Fong LY; Mancini R; Nakagawa H; Rustgi AK; Huebner K
    Cancer Res; 2003 Jul; 63(14):4244-52. PubMed ID: 12874033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression.
    Wan SG; Taccioli C; Jiang Y; Chen H; Smalley KJ; Huang K; Liu XP; Farber JL; Croce CM; Fong LY
    Int J Cancer; 2011 Jul; 129(2):331-45. PubMed ID: 20857495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
    Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
    Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.